Article By:
ChinaBio® Today
Saturday, November 12, 2022 2:40 PM EDT
Insilico Medicine signed a six-drug research collaboration with Sanofi that could be worth up to $1.2 billion. Insilico will receive up to $21.5 million in upfront and target nomination fees for each of the six targets.